Shanghai-based Contract Research Organization (CRO) Rundo Pharmaceutical R&D (Shanghai) Co., Ltd (Rundo Med-Tech) has entered into a partnership with China Internet giant Baidu to accelerate the development of digitalized smart clinical studies. The collaboration aims to leverage advanced technology to enhance the efficiency and quality of clinical research. Financial details of the partnership were not disclosed.
About Rundo Med-Tech
Rundo Med-Tech is a leading CRO that provides comprehensive one-stop services covering all phases of clinical research, from Phase I to Phase IV. Its services include strategy consultation, regulatory and registration support, clinical trial management, and more. The company is committed to delivering high-quality solutions to support the development of innovative pharmaceuticals and medical devices.
Baidu’s AI-Powered Medical Solutions
Baidu, a major player in China’s Internet and AI sectors, brings its advanced technology platform, LingYi ZhiHui, to the partnership. This AI-driven medical product, powered by Baidu Brain, offers integrated solutions for clinical auxiliary decision-making, intelligent medical records, fundus screening, chronic disease management, and medical big data services. Baidu’s solutions are already deployed in over 600 hospitals and 3,400 primary medical institutions across 31 provinces in China.
Implications for Clinical Research
The partnership between Rundo Med-Tech and Baidu is expected to significantly enhance the digitalization of clinical trials, making the process more efficient and data-driven. By integrating Baidu’s AI capabilities with Rundo Med-Tech’s clinical research expertise, the collaboration aims to drive innovation in the development of new drugs and medical technologies.
